133 related articles for article (PubMed ID: 8051541)
1. Synthesis and iron(III) binding properties of 3-hydroxypyrid-4-ones derived from kojic acid.
Molenda JJ; Basinger MA; Hanusa TP; Jones MM
J Inorg Biochem; 1994 Aug; 55(2):131-46. PubMed ID: 8051541
[TBL] [Abstract][Full Text] [Related]
2. Mobilization of iron by chiral and achiral anionic 3-hydroxypyrid-4-ones.
Molenda JJ; Jones MM; Johnston DS; Walker EM; Cannon DJ
J Med Chem; 1994 Dec; 37(25):4363-70. PubMed ID: 7996548
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of iron excretion via monoanionic 3-hydroxypyrid-4-ones.
Molenda JJ; Jones MM; Basinger MA
J Med Chem; 1994 Jan; 37(1):93-8. PubMed ID: 8289206
[TBL] [Abstract][Full Text] [Related]
4. Structure/activity relationships affecting the ability of monoanionic 3-hydroxyprid-4-ones to mobilize iron.
Molenda JJ; Jones MM; Cecil KM; Basinger MA
Chem Res Toxicol; 1994; 7(6):815-22. PubMed ID: 7696537
[TBL] [Abstract][Full Text] [Related]
5. Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.
Brock JH; Licéaga J; Arthur HM; Kontoghiorghes GJ
Am J Hematol; 1990 May; 34(1):21-5. PubMed ID: 2327400
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine.
Bergeron RJ; Streiff RR; Wiegand J; Luchetta G; Creary EA; Peter HH
Blood; 1992 Apr; 79(7):1882-90. PubMed ID: 1558978
[TBL] [Abstract][Full Text] [Related]
7. A family of hydroxypyrone ligands designed and synthesized as iron chelators.
Toso L; Crisponi G; Nurchi VM; Crespo-Alonso M; Lachowicz JI; Santos MA; Marques SM; Niclós-Gutiérrez J; González-Pérez JM; Domínguez-Martín A; Choquesillo-Lazarte D; Szewczuk Z
J Inorg Biochem; 2013 Oct; 127():220-31. PubMed ID: 23859830
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators.
Kontoghiorghes GJ; Chambers S; Hoffbrand AV
Biochem J; 1987 Jan; 241(1):87-92. PubMed ID: 3566714
[TBL] [Abstract][Full Text] [Related]
9. Competition between deferiprone, desferrioxamine and other chelators for iron and the effect of other metals.
Sheppard LN; Kontoghiorghes GJ
Arzneimittelforschung; 1993 Jun; 43(6):659-63. PubMed ID: 8352819
[TBL] [Abstract][Full Text] [Related]
10. Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload.
Kontoghiorghes GJ; Barr J; Nortey P; Sheppard L
Am J Hematol; 1993 Apr; 42(4):340-9. PubMed ID: 8493983
[TBL] [Abstract][Full Text] [Related]
11. New synthetic approach and iron chelating studies of 1-alkyl-2-methyl-3-hydroxypyrid-4-ones.
Kontoghiorghes GJ; Sheppard L; Chambers S
Arzneimittelforschung; 1987 Oct; 37(10):1099-102. PubMed ID: 3435580
[TBL] [Abstract][Full Text] [Related]
12. Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
Kontoghiorghes GJ; Aldouri MA; Hoffbrand AV; Barr J; Wonke B; Kourouclaris T; Sheppard L
Br Med J (Clin Res Ed); 1987 Dec; 295(6612):1509-12. PubMed ID: 3122880
[TBL] [Abstract][Full Text] [Related]
13. Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives.
Nurchi VM; Crisponi G; Lachowicz JI; Murgia S; Pivetta T; Remelli M; Rescigno A; Niclós-Gutíerrez J; González-Pérez JM; Domínguez-Martín A; Castiñeiras A; Szewczuk Z
J Inorg Biochem; 2010 May; 104(5):560-9. PubMed ID: 20185179
[TBL] [Abstract][Full Text] [Related]
14. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
Kontoghiorghes GJ; Sheppard L; Hoffbrand AV; Charalambous J; Tikerpae J; Pippard MJ
J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
[TBL] [Abstract][Full Text] [Related]
15. Probing the interaction of kojic acid antibiotics with iron(III) chloride by using electrospray tandem mass spectrometry.
Sudhir PR; Wu HF; Zhou ZC
Rapid Commun Mass Spectrom; 2005; 19(2):209-12. PubMed ID: 15593254
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.
Morel I; Cillard J; Lescoat G; Sergent O; Pasdeloup N; Ocaktan AZ; Abdallah MA; Brissot P; Cillard P
Free Radic Biol Med; 1992 Nov; 13(5):499-508. PubMed ID: 1334028
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel pegylated iron chelators with decreased metabolic rate.
Li J; Lu Z; Kong X; Ma Y; Zhang X; Bansal SS; Abbate V; Hider RC
Future Med Chem; 2015; 7(18):2439-49. PubMed ID: 26670054
[TBL] [Abstract][Full Text] [Related]
18. The kinetics of dimethylhydroxypyridinone interactions with iron(iii) and the catalysis of iron(iii) ligand exchange reactions: implications for bacterial iron transport and combination chelation therapies.
Harrington JM; Mysore MM; Crumbliss AL
Dalton Trans; 2018 May; 47(20):6954-6964. PubMed ID: 29721567
[TBL] [Abstract][Full Text] [Related]
19. Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators.
Lachowicz JI; Nurchi VM; Crisponi G; Jaraquemada-Pelaez Mde G; Ostrowska M; Jezierska J; Gumienna-Kontecka E; Peana M; Zoroddu MA; Choquesillo-Lazarte D; Niclós-Gutiérrez J; González-Pérez JM
J Inorg Biochem; 2015 Oct; 151():94-106. PubMed ID: 26281974
[TBL] [Abstract][Full Text] [Related]
20. The iron chelators desferrioxamine and 1-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitro.
Jeremy JY; Kontoghiorghes GJ; Hoffbrand AV; Dandona P
Biochem J; 1988 Aug; 254(1):239-44. PubMed ID: 3140797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
